Ipratropium HFA Inhaler Information

The ipratropium HFA inhaler (Atrovent® HFA) is used to treat chronic obstructive pulmonary disease (COPD), including emphysema and chronic bronchitis. Unlike older inhalers, this product uses an environmentally friendly hydrofluoroalkane (HFA) propellant, a substance that does not deplete the ozone layer.
 
This medication is usually taken four times a day. It comes in a metered-dose inhaler (called an "MDI"), and does not need to be shaken before use. Upper respiratory tract infections, sinus infections, and worsening of COPD are some of the drug's potential side effects.
 
If you have certain other medical conditions, such as glaucoma or an enlarged prostate, your healthcare provider needs to know this information when prescribing this drug. Ipratropium HFA may not be appropriate in these situations, and discussing these and other issues with your healthcare provider will help ensure the safety and effectiveness of your treatment plan.
 
(For more info, click Ipratropium HFA Inhaler. This article gives a comprehensive overview of this medication, including a discussion on how it works, available strengths, overdose symptoms, and more.)

Ipratropium HFA Inhaler Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.